Added to YB: 2026-10-02
Pitch date: 2026-09-27
PRDA.JK [neutral]
PT Prodia Widyahusada Tbk
+18.37%
current return
Author Info
Asian Century Stocks is a former buy-side investor in Asia that now focuses on researching value stocks in Asia and sharing them in his newsletter. Sign up for the newsletter.
Company Info
PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services.
Market Cap
IDR 2.5T
Pitch Price
IDR 2.8K
Price Target
N/A
Dividend
5.79%
EV/EBITDA
4.25
P/E
11.73
EV/Sales
0.77
Sector
Health Care Providers and Services
Category
N/A
Hidden Champions of Indonesia - PT Prodia Widyahusada Tbk
PRDA.JK (pass): Prodia operates 402 independent testing-lab outlets, serves almost 3 million customers annually and claims 40% Indonesian market share. First-half 2026 revenue grew 9% and net profit 11%, but testing activity remains below its pandemic boom and it is unclear whether the bottom is in. With Google Trends flattening and hospitals able to use in-house or affiliated labs, the evidence is insufficient to establish Prodia as a long-term winner.
Read full article (1 min)